Results 111 to 120 of about 66,910 (129)

Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis. [PDF]

PLOS Glob Public Health
Kim C, Sweeney S, Sohn H, Knight GM, McQuaid CF.   +4 more
europepmc   +1 more source

Effect of guideline-concordant, appropriate, and effective antimicrobial treatment on patient outcome in multidrug-resistant (MDR) infections. [PDF]

Microbiol Spectr
Sindi FA, Boubsit A, Alkhayat E, Daghestani A, Albaradie O, Khan MA, Shamas N, Hala S, Awadh A.   +8 more
europepmc   +1 more source

Investigating the Molecular Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacterales (ESBL-E) Among Patients Admitted to the Intensive Care Unit. [PDF]

Open Forum Infect Dis
Sharara SL, Simner PJ, Bergman Y, Jacobs E, Fiawoo S, Klein EY, Cosgrove SE, Tamma PD.   +7 more
europepmc   +1 more source

Timeliness of Broad-Spectrum Antibiotic De-escalation and Mortality in Emergency Department Patients With Sepsis: A Retrospective Hierarchical Logistic Regression Study. [PDF]

Cureus
Farsani A, Thandi P, Htway Z.
europepmc   +1 more source

The association between unbound ceftriaxone area under the curve in the first 24 treatment hours and longitudinal C-reactive protein response in critically ill patients: an observational study. [PDF]

Intensive Care Med
Meenks SD, Aydeniz E, van Bussel BCT, le Noble JLML, Janssen PKC.   +4 more
europepmc   +1 more source

Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and Analysis. [PDF]

Clin Transl Sci
Smith NM, Ho BM, Bar KJ, Gama L, Dziubla G, Koup RA, Pensiero M, Serebryannyy L, Caskey M, Wilkin TJ, Wood TD, Morse GD, Venuto CS, Cha R, Ma Q.   +14 more
europepmc   +1 more source